| PABPC4L |
P0CB38
|
poly(A) binding protein cytoplasmic 4 like
|
|
5.3E-04 |
1.000 |
|
| C4orf54 |
D6RIA3
|
chromosome 4 open reading frame 54
|
|
9.3E-09 |
0.931 |
|
| C9orf43 |
Q8TAL5
|
chromosome 9 open reading frame 43
|
|
4.4E-11 |
1.000 |
|
| PARK3 |
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
|
0.821 |
0.038 |
| ETM2 |
|
essential tremor 2
|
|
|
0.931 |
0.038 |
| NBPF9 |
P0DPF3
|
NBPF member 9
|
|
9.5E-39 |
0.931 |
0.038 |
| NBPF8 |
Q3BBV2
|
NBPF member 8
|
|
1.4E-07 |
0.931 |
0.038 |
| CCAL1 |
|
chondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis)
|
|
|
0.890 |
0.038 |
| LGI2 |
Q8N0V4
|
leucine rich repeat LGI family member 2
|
|
1.5E-06 |
0.839 |
0.077 |
| CUP2Q35 |
|
Syndactyly, type I
|
|
|
0.839 |
0.077 |
| TMEM230 |
Q96A57
|
transmembrane protein 230
|
|
1.8E-04 |
0.769 |
0.115 |
| LAMB4 |
A4D0S4
|
laminin subunit beta 4
|
Enzyme modulator
|
1.6E-42 |
0.861 |
0.115 |
| DUH1 |
|
Dyschromatosis universalis hereditaria
|
|
|
0.890 |
0.115 |
| OFC2 |
|
orofacial cleft 2
|
|
|
0.931 |
0.115 |
| SLC4A3 |
P48751
|
solute carrier family 4 member 3
|
Transporter
|
1.2E-05 |
0.751 |
0.154 |
| DIRC1 |
Q969H9
|
disrupted in renal carcinoma 1
|
|
|
0.861 |
0.154 |
| ARFGAP1 |
Q8N6T3
|
ADP ribosylation factor GTPase activating protein 1
|
|
1.5E-03 |
0.839 |
0.154 |
| WT4 |
|
Wilms tumor-4
|
|
|
0.821 |
0.154 |
| FAM136A |
Q96C01
|
family with sequence similarity 136 member A
|
|
5.9E-04 |
0.890 |
0.154 |
| KCNK18 |
Q7Z418
|
potassium two pore domain channel subfamily K member 18
|
|
1.4E-03 |
0.780 |
0.192 |
| TAS2R62P |
|
taste 2 receptor member 62 pseudogene
|
|
|
0.729 |
0.192 |
| CABYR |
O75952
|
calcium binding tyrosine phosphorylation regulated
|
|
2.3E-06 |
0.792 |
0.192 |
| ARVD3 |
|
arrhythmogenic right ventricular dysplasia 3
|
|
|
0.792 |
0.192 |
| SDHAF3 |
Q9NRP4
|
succinate dehydrogenase complex assembly factor 3
|
|
2.6E-03 |
0.821 |
0.192 |
| IL17REL |
Q6ZVW7
|
interleukin 17 receptor E like
|
|
1.9E-03 |
0.861 |
0.192 |